FDA Guidance titled “Further Testing of Donations that are Reactive on a Licensed Donor Screening Test for Antibodies to Hepatitis C Virus; Guidance for Industry” was released on October 2, 2019 and recommends that CTS modify our current HCV reflex testing algorithm to support these best practices. The new algorithm will take effect on April 20, 2020.
Check out the Communication page for the complete details by clicking the link: Communications
CTS Spotlight at 2018 AABB Annual Meeting Sunday, October 14, 2018 at 1:30 PM: Scientific Oral ...
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm thi...
CTS lab staff recently participated in a Kaizen and determined emailed Daily Shipment Schedules to b...